The Inside the Clinic series is a video series of various experts at John Theurer Cancer Center speaking to a number of approaches in multiple myeloma, non-Hogkin lymphoma, CAR T-cell therapy, and next-generation sequencing.
EP. 1: Inside the Clinic: JTCC Experts Highlight Pivotal Ongoing Trials in Multiple Myeloma
David Siegel, MD, PhD, Noa Biran, MD, and David H. Vesole, MD, PhD, discuss ongoing clinical trials in multiple myeloma.
Watch
EP. 2: Inside the Clinic: JTCC Experts Highlight Key Takeaways from ASH 2021
David Siegel, MD, PhD, Noa Biran, MD, and David H. Vesole, MD, PhD, discuss key takeaways from ASH 2021.
EP. 3: Inside the Clinic: JTCC Experts Highlight Next Steps With CAR T-Cell Therapy
Lori A. Leslie, MD, and Andre H. Goy, MD, discuss next steps with CAR T-cell therapy.
EP. 4: Inside the Clinic: JTCC Experts Discuss Retreatment With CAR T-Cell Therapy
Lori A. Leslie, MD, and Andre H. Goy, MD, discuss retreatment with CAR T-cell therapy.
EP. 5: Inside the Clinic: JTCC Experts Highlight Optimal Strategies for CAR T-Cell–Related AEs
Lori A. Leslie, MD, and Andre H. Goy, MD, discuss optimal strategies for CAR T-cell–related adverse effects.
EP. 6: Inside the Clinic: JTCC Experts Discuss Approaches to CAR T-Cell Therapy
Lori A. Leslie, MD, and Andre H. Goy, MD, discuss approaches to CAR T-cell therapy.
EP. 7: Inside the Clinic: JTCC Experts Share Strategies for When CAR T-Cell Therapy Is Not an Option
Lori A. Leslie, MD, and Andre H. Goy, MD, share strategies for when CAR T-cell therapy is not an option.
EP. 8: Inside the Clinic: Experts Discuss Practical Aspects of Next-Generation Sequencing
Maher Albitar, MD, and Andre H. Goy, MD, discuss practical aspects of next-generation sequencing.
EP. 9: Inside the Clinic: Experts Highlight Molecular Complexities in MCL
Maher Albitar, MD, and Andre H. Goy, MD, share insights regarding molecular complexities in mantle cell lymphoma.
EP. 10: Inside the Clinic: Experts Discuss Testing for Molecular Abnormalities in AML
Maher Albitar, MD, and Andre H. Goy, MD, discuss the importance of testing for molecular abnormalities in acute myeloid leukemia.
EP. 11: Inside the Clinic: Experts Explore Case Studies in DLBCL
Maher Albitar, MD, and Andre H. Goy, MD, discuss case studies in diffuse large B-cell lymphoma.
DK210 (EGFR) Induces Immune Response Without Increased CRS or Regulatory T Cells in Solid Tumors
Siglec-15 Represents Potential Therapeutic Target in NSCLC, Other Solid Tumors
Radiomic Biomarkers Predict Response in Lung and Liver Uveal Melanoma Metastases
BT7480 Shows Preliminary Activity in Nectin-4+, CD137+ Tumors